Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes.
D. Fuller, A. Falchook, T. Crabtree, B. Kane +5 more
Researcher profile · Semantic Scholar
D. Fuller, A. Falchook, T. Crabtree, B. Kane +5 more
B. Zachariah, C. Gwede, J. James, J. Ajani +7 more
Kyle Wang, Ronald C. Chen, B. Kane, C. Medbery +4 more
B. Magee, C. Coyle, Mike Kirby, B. Kane +1 more
D. Fuller, T. Crabtree, B. Kane, C. Medbery +5 more
Mike Kirby, B. Kane, P. C. Williams
B. Zachariah, J. James, C. Gwede, J. Ajani +5 more
Edward Levine, Paul A. Burt, Ronald Stout, B. Kane
K. Lui, K. Wang, R.-C. Chen, B. Kane +5 more
S. Alfaifi, J. Kim, S. Rathod, W. Hunter +10 more
R. Meier, I. Kaplan, D. Bloch, Ronald Chen +6 more
D. Fuller, B. Kane, T. Crabtree, C. Medbery +4 more
D. Fuller, B. Kane, C. Medbery, K. Underhill +3 more
D. Fuller, B. Kane, K. Underhill, J. Gray +2 more
D. Fuller, B. Kane, C. Medbery, K. Underhill +3 more